HOME >> MEDICINE >> NEWS
Now is a pivotal point in history to abolish state execution

This is a pivotal point in history for countries to consider evidence that demonstrates the barbarity of lethal injection and abolish state execution, states an editorial in this week's issue of The Lancet.

Last year The Lancet published a paper, which found that despite a theoretically lethal dose of the barbiturate thiopental, given before the injection of pancuronium to paralyse breathing muscles and potassium chloride to stop the heart, 21 of 49 executed US inmates had postmortem thiopental concentrations consistent with consciousness (See Lancet 2005; 365: 141214). Now, a Californian judge--Judge Jeremy Fogel--has ruled that the state must either rely solely on thiopental, or else have a qualified individual confirm unconsciousness before the injection of pancuronium and potassium chloride, in order to avoid excessive pain. As a result, Californian officials have had to postpone the execution of a convicted murderer by lethal injection after they were unable to find medical personnel willing to participate. Involvement in executions contradicts the principles of many professional organisations in the US, including the American Medical Association.

The Lancet comments: "This is a pivotal point in history. A moment when individuals, like Judge Fogel, and the anaesthetists who refused to participate, have given voice to their conscience. They have articulated the concerns of an increasing number of Americans, whose support for capital punishment has dropped from 80% to 64% in the past decade. It is a voice to be heeded. As Judge Fogel noted, the Eighth Amendment has been interpreted as prohibiting punishments that are 'incompatible with the evolving standards of decency that mark the progress of a maturing society'. In 2004, China, Iran, Vietnam, and the USA accounted for 97% of the world's executions. From which of these countries will a mature society take the lead, and abolish the atrocity of state execution?"


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
2-Mar-2006


Page: 1

Related medicine news :

1. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
2. Approval to start US BTT pivotal trial
3. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
4. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
5. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
6. Metabolic syndrome points to heart health
7. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
8. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
9. System to pinpoint airline passengers who contaminate cabins
10. Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
11. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Now pivotal point history abolish state execution

(Date:11/28/2014)... CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was created ... communities by giving to local charities and causes. ... Holiday, coincides with the kickoff of the holiday shopping ... is to shopping and Cyber Monday is to online ...
(Date:11/28/2014)... Now that the holiday season is here, ... nation's leading cash-for-junk-cars companies, is improving their cash offers ... competitive and help bring a little bit more joy ... year. , Along with purchasing expensive gifts for family ... deal with large travel expenses during the holiday season. ...
(Date:11/28/2014)... 28, 2014 Novatus, a leading ... Release v5.1 which provides customers with greater reporting ... , “As we continue to evolve and ... more functionality and improved performance in response to ... for Novatus. “With the enhancements that we have ...
(Date:11/28/2014)... Wisconsin (PRWEB) November 28, 2014 Dr. ... plastic surgeons , announced the expansion of Quintessa Aesthetic ... center will be located at W307 N1497 Golf Road ... , According to Dr. Campbell, the new Delafield location ... procedures for patients, including: Botox, filler injectables ...
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded cosmetic ... Event for those in the area that would like to learn ... Glow will take place on December 11, 2014, from 6:00 p.m. ... of Houston at 4208 Richmond Ave. , “We want to ... come and celebrate the season with us on December 11, 2014 ...
Breaking Medicine News(10 mins):Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3
(Date:11/28/2014)... Quebec , Nov. 28, 2014  Valeant ... (TSX: VRX) today announced that its wholly owned ... aggregate principal amount of its outstanding 6.875% Senior ... " Notes ") on December 29, 2014 and ... the Notes. Following the redemption, approximately US$500 million ...
(Date:11/28/2014)... The market for both conventional and digital ... in 2014 according to Kalorama Information.  The healthcare market ... incidence of disease are driving the market.  The finding ... X-Ray: World Market Analysis . ... can be obtained at: http://www.kaloramainformation.com/Ray-Digital-8507029/ ...
(Date:11/28/2014)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ... the research, development and commercialization of prescription ophthalmic ... with Deerfield Management and certain of its affiliates ... of preferred stock to Deerfield with an aggregate ... satisfaction of certain closing conditions. Alimera has also ...
Breaking Medicine Technology:Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018 2Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 2Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 3Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3
Cached News: